Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.
…
continue reading
1
Biliary Tract Cancers | Striving for Consensus: Optimizing the Current and Future Management of Biliary Tract Cancers
2:14:33
2:14:33
Play later
Play later
Lists
Like
Liked
2:14:33
Featuring slide presentations and related discussion from Dr Lipika Goyal, Dr James J Harding, Dr Milind Javle and Dr Robin K (Katie) Kelley, including the following topics: Current Role of Immunotherapeutic Strategies for Advanced Biliary Tract Cancers (BTCs) — Dr Kelley (0:00) Case: A man in his late 60s with advanced distal cholangiocarcinoma tr…
…
continue reading
Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors | Faculty Presentation 2: Later-Line Treatment for Advanced NETs — Pamela Kunz, MD CME information and select publicationsBy Dr. Neil Love
…
continue reading
1
Neuroendocrine Tumors | Simron Singh, MD, MPH
22:44
22:44
Play later
Play later
Lists
Like
Liked
22:44
Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors | Faculty Presentation 1: First-Line Therapy for Advanced Neuroendocrine Tumors (NETs) — Simron Singh, MD, MPH CME information and select publicationsBy Dr. Neil Love
…
continue reading
1
Neuroendocrine Tumors | Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors
59:20
59:20
Play later
Play later
Lists
Like
Liked
59:20
Featuring perspectives from Dr Pamela Kunz and Dr Simron Singh, including the following topics: Introduction (0:00) Overview (4:04) Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors (NETs) (27:07) Multitarget Tyrosine Kinase Inhibitors for the Treatment of NETs (39:37) Other New Advances in the Management of NETs (50:29) CME informati…
…
continue reading
1
Gastrointestinal Cancers | John Strickler, MD
56:47
56:47
Play later
Play later
Lists
Like
Liked
56:47
Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers | Faculty Presentation 1: HER2-Targeted Strategies for HER2-Positive Gastroesophageal and Colorectal Cancers — John Strickler, MD CME information and select publicationsBy Dr. Neil Love
…
continue reading
1
Gastrointestinal Cancers | Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers
1:00:59
1:00:59
Play later
Play later
Lists
Like
Liked
1:00:59
Featuring perspectives from Dr Tanios Bekaii-Saab and Dr John Strickler, including the following topics: Introduction: Back-to-School Special (0:00) Biomarker Assays in Advanced Gastrointestinal (GI) Cancers (10:12) Sequencing of Treatment for HER2-Positive GI Cancers (28:37) Toxicities Associated with Anti-HER2 Treatment (48:32) Novel Agents and S…
…
continue reading
1
Gastrointestinal Cancers | Tanios Bekaii-Saab, MD
32:21
32:21
Play later
Play later
Lists
Like
Liked
32:21
Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers | Faculty Presentation 2: Emerging Role of HER2-Targeted Therapy in Advanced Biliary Tract Cancers (BTCs) — Tanios Bekaii-Saab, MD CME information and select publicationsBy Dr. Neil Love
…
continue reading
1
Non-Small Cell Lung Cancer with an EGFR Mutation | Striving for Consensus: Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation
2:03:01
2:03:01
Play later
Play later
Lists
Like
Liked
2:03:01
Featuring slide presentations and related discussion from Dr Pasi A Jänne, Prof Tom John, Dr Zofia Piotrowska and Dr Alexander I Spira, including the following topics: Recent Advances in the Management of Localized and Locally Advanced Non-Small Cell Lung Cancer (NSCLC) with an EGFR Mutation — Prof John (0:00) First-Line Treatment for Advanced NSCL…
…
continue reading
1
Dedifferentiated Liposarcoma | Oncology Today with Dr Neil Love: Optimizing the Management of Dedifferentiated Liposarcoma
1:15:00
1:15:00
Play later
Play later
Lists
Like
Liked
1:15:00
Featuring perspectives from Dr Mrinal Gounder, including the following topics: Epidemiology, classification, genetics and diagnosis of sarcomas (0:00) Contemporary medical treatment of sarcomas (5:29) Targeted therapy for the treatment of sarcomas (9:01) Incidence, pathophysiology, classifications and clinical manifestations of liposarcomas (16:27)…
…
continue reading
1
HR-Positive and Triple-Negative Metastatic Breast Cancer | Inside the Issue: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer
1:02:35
1:02:35
Play later
Play later
Lists
Like
Liked
1:02:35
Featuring perspectives from Prof Peter Schmid and Dr Sara M Tolaney, including the following topics: Introduction: Pharmacology and Sequencing of Antibody-Drug Conjugates (ADCs) in Metastatic Breast Cancer (mBC) (0:00) Expanding Role of TROP2-Directed ADCs in mBC Management — Dr Tolaney (21:42) Other Targets for ADC Therapy in mBC — Prof Schmid (44…
…
continue reading
1
HR-Positive and Triple-Negative Metastatic Breast Cancer | Professor Peter Schmid, FRCP, MD, PhD
48:59
48:59
Play later
Play later
Lists
Like
Liked
48:59
Inside the Issue: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer | Faculty Presentation 2: Other Targets for ADC Therapy in mBC — Professor Peter Schmid, FRCP, MD, PhD CME information and select publicationsBy Dr. Neil Love
…
continue reading
1
HR-Positive and Triple-Negative Metastatic Breast Cancer | Sara M Tolaney, MD, MPH
28:21
28:21
Play later
Play later
Lists
Like
Liked
28:21
Inside the Issue: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer | Faculty Presentation 1: Expanding Role of TROP2-Directed Antibody-Drug Conjugates (ADCs) in Metastatic Breast Cancer (mBC) Management — Sara M Tolaney, MD, MPH CME information and select publications…
…
continue reading
1
Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Management of Metastatic Urothelial Bladder Cancer (Companion Faculty Lecture)
43:59
43:59
Play later
Play later
Lists
Like
Liked
43:59
Featuring a slide presentation and related discussion from Dr Michiel van der Heijden, including the following topics: Efficacy and safety data from the Phase III EV-302/KEYNOTE-A39 trial comparing enfortumab vedotin/pembrolizumab to chemotherapy for patients with previously untreated metastatic urothelial bladder cancer (mUBC) (0:00) Principal fin…
…
continue reading